000 | 01923 a2200517 4500 | ||
---|---|---|---|
005 | 20250518055633.0 | ||
264 | 0 | _c20200205 | |
008 | 202002s 0 0 eng d | ||
022 | _a1878-3252 | ||
024 | 7 |
_a10.1016/j.jtemb.2019.07.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Lingjuan | |
245 | 0 | 0 |
_aThe iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment. _h[electronic resource] |
260 |
_bJournal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) _cDec 2019 |
||
300 |
_a131-138 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAldehyde Dehydrogenase _xmetabolism |
650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 |
_aDeferoxamine _xpharmacology |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracellular Space _xmetabolism |
650 | 0 | 4 |
_aIron _xmetabolism |
650 | 0 | 4 |
_aIron Chelating Agents _xpharmacology |
650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
700 | 1 | _aLi, Xiaoqing | |
700 | 1 | _aMu, Yanxi | |
700 | 1 | _aLu, Chang | |
700 | 1 | _aTang, Shiqian | |
700 | 1 | _aLu, Kun | |
700 | 1 | _aQiu, Xiaoming | |
700 | 1 | _aWei, Aili | |
700 | 1 | _aCheng, Yongjiu | |
700 | 1 | _aWei, Wei | |
773 | 0 |
_tJournal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) _gvol. 56 _gp. 131-138 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jtemb.2019.07.008 _zAvailable from publisher's website |
999 |
_c30057957 _d30057957 |